menu search

Shareholder investigation: halper sadeh llc investigates cnce, vlta, gmgi

NEW YORK, Jan. 22, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...

January 22, 2023, 2:46 pm

Reata pharmaceuticals: binary catalyst unlocking

Bardoxolone's Complete Response Letter caused the stock to lose much of its share price last year. The other lead medicine (omaveloxolone) is going to...

January 22, 2023, 9:39 am

Schrodinger: solving the critical need for ai/ml in the biopharma industry

SDGR's valuable segment is its software business which represents majority of the revenue. There is an increasing demand for AI/ML capabilities by bio...

January 21, 2023, 11:46 pm

Abbott under federal investigation over baby formula—here's how the pharmaceutical giant got here

The FDA found multiple unsanitary conditions at Abbott's plant in Michigan last year, following its recall of its baby formula, prompting a nationwide...

January 21, 2023, 3:03 pm

Inclusive capital takes a stake in bayer — 3 ways it may build value with a sustainable focus

Jeff Ubben's Inclusive Capital took a stake in Bayer. The pharmaceutical giant has a big footprint in t...

January 21, 2023, 8:43 am

This dow jones stock crushed the market in 2022 -- can it do it again?

This pharmaceutical was the second-best performing Dow Jones stock in 2022 behind the energy giant Chev...

January 21, 2023, 7:40 am

Why concert pharmaceuticals stock rocketed higher this week

The company is changing hands in a deal worth at least $576 million....

January 20, 2023, 6:15 pm

Defence to present at the 9th annual immuno-oncology 360 summit in new-york february 7-10, 2023

Vancouver, British Columbia--(Newsfile Corp. - January 20, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the...

January 20, 2023, 4:30 pm

Jpmorgan sees another 20% upside in regeneron shares: this is why

Shares of Regeneron pharmaceuticals Inc (NASDAQ: REGN) have already gained about 25% since early Septem...

January 20, 2023, 12:38 pm

Autolus therapeutics announces board changes

LONDON, Jan. 20, 2023 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharma...

January 20, 2023, 12:00 pm

Bioasis announces filing of its quarterly financial statements and md&a for the period ending november 30, 2022

NEW HAVEN, Conn., Jan. 19, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-...

January 19, 2023, 10:05 pm

Taro to release third quarter results on january 24, 2023

HAWTHORNE, N.Y.--( BUSINESS WIRE )--Taro pharmaceutical Industries Ltd. (NYSE: TARO) announced today th...

January 19, 2023, 5:02 pm

pharmaceutical stocks pfizer, gsk, moderna come close to cracking a multibillion-dollar rsv vaccine market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the phar...

January 19, 2023, 1:41 pm

Salarius pharmaceuticals to present sp-3164 targeted protein degrader preclinical data at the inaugural molecular glue drug development summit

Dr. Aundrietta Duncan to discuss mechanism of action and SP-3164 activity in cancer models Company planning to submit an Investigational New Drug appl...

January 19, 2023, 1:30 pm

United-guardian's business is under threat, and the stock is still expensive

UG manufactures chemicals for cosmetic, pharmaceutical and medical uses. The company's start products h...

January 19, 2023, 10:46 am

Outlook therapeutics strengthens medical affairs and commercial expertise with new appointments

Outlook Therapeutics Inc (NASDAQ:OTLK) has announced the appointments of Dr Surendra Sharma as senior vice president of medical affairs and Glen Olsh...

January 19, 2023, 9:01 am

Salarius pharmaceuticals to present sp-3164 targeted protein degrader preclinical data at the inaugural molecular glue drug development summit

Dr. Aundrietta Duncan to discuss mechanism of action and SP-3164 activity in cancer models...

January 19, 2023, 8:30 am

Zymeworks shares gain on promising data for cancer drug in development with jazz pharmaceuticals

Shares of Zymeworks Inc. ZYME, rallied 14% in premarket trading on Thursday after the company and Jazz pharmac...

January 19, 2023, 8:07 am

Soligenix invited to present at the virtual investor summit event

Focusing on 25 micro-cap companies with key catalysts and/or strong performance in the current market PRINCETON, N.J. , Jan. 19, 2023 /PRNewswire/ --�...

January 19, 2023, 7:30 am

J&j discontinues hiv trial in latest setback to vaccine pursuit

Johnson & Johnson (NYSE:JNJ)'s wholly-owned pharmaceutical company Janssen ...

January 19, 2023, 2:57 am


Search within

Pages Search Results: